Opens in a new tab

Dr. Hu Pinjin

Chinese name: 胡品津
Professor, Chief Physician, Doctoral Supervisor . Gastroenterology and Inflammatory Bowel Disease
Dr. Hu Pinjin is Chief Expert in Gastroenterology at the Sixth Affiliated Hospital of Sun Yat-sen University and former Chairman of the Asian Organization for Crohn's and Colitis. He has devoted more than forty years to inflammatory bowel disease, Helicobacter pylori infection and functional gastrointestinal disorders, and led the development of Chinese consensus for inflammatory bowel disease.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

40+
Years in clinical practice
300+
Published papers
7
Textbooks and teaching materials edited

  • The Physician

About Dr. Hu Pinjin

Dr. Hu Pinjin is Chief Expert in Gastroenterology at the Sixth Affiliated Hospital of Sun Yat-sen University and former Director of its Department of Gastroenterology. A former Chairman of the Asian Organization for Crohn's and Colitis, he has devoted more than forty years to inflammatory bowel disease, Helicobacter pylori infection, functional gastrointestinal disorders and liver disease, and led the development of Chinese consensus on inflammatory bowel disease. He was a visiting researcher at the MD Anderson Cancer Center, has published more than three hundred papers, and edited national textbooks and monographs. He is a recipient of the State Council Special Allowance.
1、Chief Expert in Gastroenterology at the Sixth Affiliated Hospital of Sun Yat-sen University
2、Former Chairman of the Asian Organization for Crohn’s and Colitis
3、Editor-in-Chief of the Chinese Journal of Inflammatory Bowel Diseases
4、Former Vice Chairman of the Chinese Society of Gastroenterology
5、Recipient of the State Council Special Allowance and multiple provincial science and technology awards
6、Editor of more than seven national textbooks, including Internal Medicine and Differential Diagnosis of Internal Diseases

Dr. Hu Pinjin ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Inflammatory bowel disease

He diagnoses and treats Crohn's disease and ulcerative colitis with individualised medical therapy, including immunosuppressants, biologics and therapeutic drug monitoring, so that patients achieve lasting remission, avoid complications and maintain a good quality of life over the long term in daily practice.

Helicobacter pylori infection

He manages Helicobacter pylori infection and its related diseases, using appropriate eradication regimens and follow-up testing, so that peptic ulcers and gastric inflammation are controlled and the risk of gastric cancer is reduced for patients at home and abroad in everyday care.

Functional gastrointestinal disorders

He treats functional dyspepsia, irritable bowel syndrome and other functional gastrointestinal disorders with careful evaluation, dietary advice, drug therapy and attention to psychological factors, so that troublesome symptoms improve and patients regain confidence in daily life and long-term wellbeing over time.

More： chronic liver disease——diagnosis and treatment; small bowel disease——endoscopy; chronic diarrhoea——evaluation; peptic ulcer——treatment; gastrointestinal bleeding——management

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. EXPLORE Study: Suboptimal Response to Anti-TNF Therapy in Chinese IBD Patients
This multicenter analysis evaluated how often patients with inflammatory bowel disease in China respond poorly to first-line anti-TNF therapy, identifying clinical indicators of suboptimal response. It helps clinicians adjust biologic treatment earlier for ulcerative colitis and Crohn’s disease patients who may not benefit sufficiently.
2. Thalidomide for Refractory Crohn’s Disease: A Randomized Controlled Trial
This double-blind, double-center randomized controlled trial tested thalidomide in adults with refractory Crohn’s disease, assessing clinical efficacy and safety. The results support an immunomodulatory option for patients whose Crohn’s disease has not responded to conventional or biologic therapies, guiding difficult treatment decisions.
3. Ustekinumab Dose Escalation in Inflammatory Bowel Disease: A Meta-Analysis
This systematic review and meta-analysis examined loss of response to ustekinumab and the benefit of dose escalation in Crohn’s disease and ulcerative colitis. It offers practical guidance for managing patients who lose response during maintenance biologic therapy in real-world practice.
4. Genotype-Guided Thiopurine Dosing to Reduce Leukopenia in IBD
This study investigated DNA-thioguanine nucleotides as a marker for thiopurine-induced leukopenia after NUDT15 genotype-guided dosing in Chinese patients with inflammatory bowel disease. It supports safer, personalized thiopurine treatment and lower blood-toxicity risk for IBD patients needing immunomodulators in clinical practice.
5. Endoscopic Stricturotomy for Small Bowel Strictures in Crohn’s Disease
This report with video describes device-assisted enteroscopy-based stricturotomy for small bowel strictures associated with Crohn’s disease, an endoscopic alternative to surgery. It is relevant for patients with Crohn’s-related intestinal narrowing who wish to avoid or delay bowel resection in selected cases.
6. Official Profile of an Inflammatory Bowel Disease Specialist
This official doctor profile summarizes long experience in gastroenterology and inflammatory bowel disease, including diagnosis and medical treatment of Crohn’s disease, ulcerative colitis, and other digestive disorders, helping patients locate an experienced IBD specialist for consultation and long-term care in Guangzhou.
  • Affiliated Hospital

Where Dr. Hu Pinjin practices

Guangzhou

The Sixth Affiliated Hospital, Sun Yat-sen University

Chinese name: 中山大学附属第六医院
Founded in 1964, Sun Yat-sen University Sixth Affiliated Hospital is a Grade-A tertiary hospital renowned for gastrointestinal surgery and reproductive medicine, holding 3 national key specialties and the world's largest IBD case volume, opening 1,497 beds and ranking A+ nationally.
Since 1964
62 years of care
1,497
Licensed beds
6,415
Colorectal surgeries (2024)
1.66 million
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Hu Pinjin?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Hu Pinjin.